Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-020-0308-3 http://scihub22266oqcxt.onion/10.1038/s41577-020-0308-3 32273594!7143200!32273594     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2020 ; 20 (5): 269-270 Nephropedia Template TP {{tp|p=32273594|t=2020. COVID-19: immunopathology and its implications for therapy |pdf=|usr=}}{{32273594}} gab.com Text COVID-19: immunopathology and its implications for therapy JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32273594 #FOAvip Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia, exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; however, whether this is protective or pathogenic remains to be determined. Defining the immunopathological changes in patients with COVID-19 provides potential targets for drug discovery and is important for clinical management. Twit Text FOAVip COVID-19: immunopathology and its implications for therapy ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32273594 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32273594 #FOAvip English Wikipedia <ref>{{Cite pmid|32273594}}</ref> COVID-19: immunopathology and its implications for therapy #MMPMID32273594 Cao X Nat Rev Immunol 2020[May]; 20 (5): 269-270 PMID32273594show ga Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia, exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; however, whether this is protective or pathogenic remains to be determined. Defining the immunopathological changes in patients with COVID-19 provides potential targets for drug discovery and is important for clinical management. |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*immunology/*pathology/therapy[MESH] |Cytokines/immunology[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Inflammation/pathology[MESH] |Mesenchymal Stem Cell Transplantation[MESH] |Pandemics[MESH]COVID-19: immunopathology and its implications for therapy (epmc).pdf DeepDyve Pubget Overpricing